Mode of action of β-cyclodextrin as an absorption enhancer of the water-soluble drug meglumine antimoniate
Authors:
- Rosemary OchoaRORosemary Ochoa
- Adriano M.C. PimentaAPAdriano M.C. Pimenta
- Lucas A.M. FerreiraLFLucas A.M. Ferreira
- Alan L. MeloAMAlan L. Melo
- José B.B. da SilvaJSJosé B.B. da Silva
- Rubén D. SinisterraRSRubén D. Sinisterra
- Cynthia DemicheliCDCynthia Demicheli
- Frédéric FrézardFFFrédéric Frézard
- 1 November 2006
- journal article
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 325 (1-2) , 39-47
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Characterization of reactions of antimoniate and meglumine antimoniate with a guanine ribonucleoside at different pHBioMetals, 2006
- Role of residual Sb(III) in meglumine antimoniate cytotoxicity and MRP1-mediated resistanceChemico-Biological Interactions, 2006
- Pentavalent Antimonials: From Chemistry to the Design of New DrugsDrug Design Reviews - Online, 2005
- Oral Delivery of Meglumine Antimoniate-β-Cyclodextrin Complex for Treatment of LeishmaniasisAntimicrobial Agents and Chemotherapy, 2004
- Antimony Uptake Systems in the Protozoan Parasite Leishmania and Accumulation Differences in Antimony-Resistant ParasitesAntimicrobial Agents and Chemotherapy, 2003
- Pentavalent organoantimonial derivatives: two simple and efficient synthetic methods for meglumine antimonateApplied Organometallic Chemistry, 2003
- Physico-chemical characterization of meglumine antimoniateBioMetals, 1999
- Treatment of cutaneous antimony: intramuscular administration leishmaniasis with versus intralesionalPathogens and Global Health, 1997
- Human Leishmaniasis: Clinical, Diagnostic, and Chemotherapeutic Developments in the Last 10 YearsClinical Infectious Diseases, 1997
- NEW MECHANISMS OF DRUG RESISTANCE IN PARASITIC PROTOZOAAnnual Review of Microbiology, 1995